Shenwei Pharmaceutical announced its annual results for the year ended December 31, 2023. The group achieved a turnover of 4.517 billion yuan during the period, an increase of 14.3% over the previous year; profit attributable to shareholders of 970 million yuan, an increase of 34.14% over the previous year; profit per share of 128 points; and plans to pay the first interim dividend of 43 points per share in 2024.
神威药业发布年度业绩 股东应占溢利9.7亿元，同比增加34.14%
Shenwei Pharmaceutical announced annual results with profit attributable to shareholders of 970 million yuan, an increase of 34.14% over the previous year
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.